NASDAQ: PROF
Profound Medical Corp Stock Ownership - Who owns Profound Medical?

Insider buying vs selling

Have Profound Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arun Swarup MenawatCEO2025-05-1612,027$4.73
$56.89kBuy
Arun Swarup MenawatCEO2025-05-1510,003$4.33
$43.26kBuy

1 of 1

PROF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PROF insiders and whales buy or sell their stock.

PROF Shareholders

What type of owners hold Profound Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fil Ltd6.27%1,885,000$8.22MInstitution
Gagnon Securities LLC5.82%1,749,913$7.63MInstitution
Letko Brosseau Associates Inc4.01%1,204,250$5.25MInstitution
Raymond James Financial Inc3.13%941,879$4.11MInstitution
Gagnon Advisors LLC2.98%896,671$3.91MInstitution
Timelo Investment Management Inc2.80%840,656$3.67MInstitution
Royce Associates LP2.55%764,906$3.33MInstitution
Rosalind Advisors Inc2.30%692,185$3.02MInstitution
Arun Swarup Menawat1.95%587,089$2.56MInsider
Mmcap International Inc Spc1.63%490,859$2.14MInstitution

1 of 3

PROF vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PROF41.54%1.95%Net Buying
ANIK82.64%17.36%Net Selling
LNSR38.62%51.31%Net Selling
BSGM50.62%49.38%
MXCT66.89%11.84%Net BuyingNet Buying

Profound Medical Stock Ownership FAQ

Who owns Profound Medical?

Profound Medical (NASDAQ: PROF) is owned by 41.54% institutional shareholders, 1.95% Profound Medical insiders, and 56.51% retail investors. Arun Swarup Menawat is the largest individual Profound Medical shareholder, owning 587,089.00 shares representing 1.95% of the company. Arun Swarup Menawat's Profound Medical shares are currently valued at $2.59M.

If you're new to stock investing, here's how to buy Profound Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.